SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma receives USFDA approval for Eptifibatide Injection

10 Dec 2015 Evaluate

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Eptifibatide Injection USP, 20 mg/10 mL, 75 mg/100 mL, and 200 mg/100 mL single-use vials. This product is expected to be launched in this month. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Integrilin Injection, 20 mg/10 mL, 75 mg/100 mL, and 200 mg/100 mL of Schering Corporation.

Eptifibatide Injection is used in the treatment of acute coronary syndrome. The approved product has an estimated market size of $137 million for the twelve months ending October 2015 according to IMS.

The pharma major now has 18 ANDAs (including one tentative approval) approved out of Unit IV formulation facility in Hyderabad, India for manufacturing general injectable products. Aurobindo now has a total of 222 ANDA approvals (194 Final approvals including 10 from Aurolife Pharma LLC and 28 Tentative approvals) from USFDA.



Aurobindo Pharma Share Price

1377.00 9.30 (0.68%)
21-Apr-2026 10:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.30
Dr. Reddys Lab 1225.00
Cipla 1231.55
Zydus Lifesciences 929.90
Lupin 2326.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×